PDB Short entry for 3C9W HEADER TRANSFERASE 18-FEB-08 3C9W TITLE CRYSTAL STRUCTURE OF ERK-2 WITH HYPOTHEMYCIN COVALENTLY BOUND COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: EXTRACELLULAR SIGNAL-REGULATED KINASE 2, ERK-2, MITOGEN- COMPND 5 ACTIVATED PROTEIN KINASE 2, MAP KINASE 2, MAPK 2, P42-MAPK, ERT1; COMPND 6 EC: 2.7.11.24; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 GENE: ERK2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS ERK, ACETYLATION, ATP-BINDING, CELL CYCLE, KINASE, NUCLEOTIDE- KEYWDS 2 BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, KEYWDS 3 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR R.J.ROSENFELD REVDAT 5 01-NOV-23 3C9W 1 REMARK LINK REVDAT 4 25-OCT-17 3C9W 1 REMARK REVDAT 3 24-FEB-09 3C9W 1 VERSN REVDAT 2 07-OCT-08 3C9W 1 JRNL REVDAT 1 08-JUL-08 3C9W 0 JRNL AUTH G.RASTELLI,R.ROSENFELD,R.REID,D.V.SANTI JRNL TITL MOLECULAR MODELING AND CRYSTAL STRUCTURE OF JRNL TITL 2 ERK2-HYPOTHEMYCIN COMPLEXES JRNL REF J.STRUCT.BIOL. V. 164 18 2008 JRNL REFN ISSN 1047-8477 JRNL PMID 18571434 JRNL DOI 10.1016/J.JSB.2008.05.002 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.80 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 23771 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1215 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.56 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1520 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.39 REMARK 3 BIN R VALUE (WORKING SET) : 0.2800 REMARK 3 BIN FREE R VALUE SET COUNT : 88 REMARK 3 BIN FREE R VALUE : 0.3400 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5478 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 257 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.46 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.40000 REMARK 3 B22 (A**2) : -0.90000 REMARK 3 B33 (A**2) : 0.50000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.15000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.354 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.265 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 23.636 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.899 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5666 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7676 ; 1.305 ; 1.988 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 668 ; 5.982 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 268 ;40.670 ;24.104 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1014 ;19.736 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 36 ;22.359 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 842 ; 0.092 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4264 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 3000 ; 0.222 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3828 ; 0.313 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 340 ; 0.172 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 102 ; 0.210 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 14 ; 0.235 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3431 ; 0.630 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5468 ; 1.136 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2488 ; 1.457 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2202 ; 2.379 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3C9W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 20-FEB-08. REMARK 100 THE DEPOSITION ID IS D_1000046524. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23791 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 2.600 REMARK 200 R MERGE (I) : 0.07200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.58800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1ERK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS PH 8.5, 20% PEG 4000, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 58.64900 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 ASP A 175 REMARK 465 HIS A 176 REMARK 465 ASP A 177 REMARK 465 HIS A 178 REMARK 465 THR A 179 REMARK 465 GLY A 180 REMARK 465 PHE A 181 REMARK 465 LEU A 182 REMARK 465 THR A 183 REMARK 465 GLU A 184 REMARK 465 TYR A 185 REMARK 465 VAL A 186 REMARK 465 ALA A 187 REMARK 465 GLY A 355 REMARK 465 TYR A 356 REMARK 465 ARG A 357 REMARK 465 SER A 358 REMARK 465 ALA B 2 REMARK 465 ALA B 3 REMARK 465 ALA B 4 REMARK 465 ALA B 5 REMARK 465 ASP B 175 REMARK 465 HIS B 176 REMARK 465 ASP B 177 REMARK 465 HIS B 178 REMARK 465 THR B 179 REMARK 465 GLY B 180 REMARK 465 PHE B 181 REMARK 465 LEU B 182 REMARK 465 THR B 183 REMARK 465 GLU B 184 REMARK 465 TYR B 185 REMARK 465 VAL B 186 REMARK 465 ALA B 187 REMARK 465 GLY B 355 REMARK 465 TYR B 356 REMARK 465 ARG B 357 REMARK 465 SER B 358 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 377 O HOH A 484 2.14 REMARK 500 O LYS A 115 O HOH A 434 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 7 -102.46 54.53 REMARK 500 ASN A 25 63.81 60.08 REMARK 500 ILE A 29 -50.32 -121.97 REMARK 500 GLU A 31 81.04 -153.50 REMARK 500 ALA A 33 -103.84 95.26 REMARK 500 ARG A 146 -2.41 75.06 REMARK 500 ASP A 147 46.56 -150.55 REMARK 500 ASP A 165 89.77 50.82 REMARK 500 ASP A 173 67.01 -115.36 REMARK 500 LEU A 198 -75.84 -86.47 REMARK 500 ASN A 199 -120.65 -93.52 REMARK 500 SER A 200 -179.16 -67.87 REMARK 500 LYS A 201 29.80 -70.76 REMARK 500 ARG A 223 118.81 -170.67 REMARK 500 LEU A 292 59.51 -96.47 REMARK 500 ASP A 316 89.78 -153.92 REMARK 500 MET A 331 -14.75 -152.69 REMARK 500 GLU A 332 158.32 -38.55 REMARK 500 ASP A 334 -96.12 3.17 REMARK 500 ASP A 335 11.24 58.55 REMARK 500 ARG B 13 64.64 39.96 REMARK 500 GLU B 31 -169.08 -129.06 REMARK 500 ALA B 33 -66.03 73.86 REMARK 500 ARG B 146 -19.52 88.54 REMARK 500 ASP B 165 86.37 61.80 REMARK 500 ASN B 199 -131.45 -131.72 REMARK 500 SER B 200 -176.43 -59.28 REMARK 500 LYS B 201 35.89 -68.33 REMARK 500 SER B 246 176.58 -59.86 REMARK 500 LEU B 292 40.78 -94.47 REMARK 500 LYS B 328 94.32 -165.05 REMARK 500 GLU B 332 156.07 -49.06 REMARK 500 LEU B 333 -15.52 86.08 REMARK 500 ASP B 334 98.47 71.71 REMARK 500 ASP B 335 -0.74 -140.56 REMARK 500 ARG B 351 -18.87 -39.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HMY A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HMY B 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ERK RELATED DB: PDB REMARK 900 STRUCTURE OF SIGNAL-REGULATED KINASE REMARK 900 RELATED ID: 2E14 RELATED DB: PDB REMARK 900 THE STRUCTURE OF ERK2 IN COMPLEX WITH FR148083 DBREF 3C9W A 2 358 UNP P63086 MK01_RAT 2 358 DBREF 3C9W B 2 358 UNP P63086 MK01_RAT 2 358 SEQRES 1 A 357 ALA ALA ALA ALA ALA ALA GLY PRO GLU MET VAL ARG GLY SEQRES 2 A 357 GLN VAL PHE ASP VAL GLY PRO ARG TYR THR ASN LEU SER SEQRES 3 A 357 TYR ILE GLY GLU GLY ALA TYR GLY MET VAL CYS SER ALA SEQRES 4 A 357 TYR ASP ASN LEU ASN LYS VAL ARG VAL ALA ILE LYS LYS SEQRES 5 A 357 ILE SER PRO PHE GLU HIS GLN THR TYR CYS GLN ARG THR SEQRES 6 A 357 LEU ARG GLU ILE LYS ILE LEU LEU ARG PHE ARG HIS GLU SEQRES 7 A 357 ASN ILE ILE GLY ILE ASN ASP ILE ILE ARG ALA PRO THR SEQRES 8 A 357 ILE GLU GLN MET LYS ASP VAL TYR ILE VAL GLN ASP LEU SEQRES 9 A 357 MET GLU THR ASP LEU TYR LYS LEU LEU LYS THR GLN HIS SEQRES 10 A 357 LEU SER ASN ASP HIS ILE CYS TYR PHE LEU TYR GLN ILE SEQRES 11 A 357 LEU ARG GLY LEU LYS TYR ILE HIS SER ALA ASN VAL LEU SEQRES 12 A 357 HIS ARG ASP LEU LYS PRO SER ASN LEU LEU LEU ASN THR SEQRES 13 A 357 THR CYS ASP LEU LYS ILE CYS ASP PHE GLY LEU ALA ARG SEQRES 14 A 357 VAL ALA ASP PRO ASP HIS ASP HIS THR GLY PHE LEU THR SEQRES 15 A 357 GLU TYR VAL ALA THR ARG TRP TYR ARG ALA PRO GLU ILE SEQRES 16 A 357 MET LEU ASN SER LYS GLY TYR THR LYS SER ILE ASP ILE SEQRES 17 A 357 TRP SER VAL GLY CYS ILE LEU ALA GLU MET LEU SER ASN SEQRES 18 A 357 ARG PRO ILE PHE PRO GLY LYS HIS TYR LEU ASP GLN LEU SEQRES 19 A 357 ASN HIS ILE LEU GLY ILE LEU GLY SER PRO SER GLN GLU SEQRES 20 A 357 ASP LEU ASN CYS ILE ILE ASN LEU LYS ALA ARG ASN TYR SEQRES 21 A 357 LEU LEU SER LEU PRO HIS LYS ASN LYS VAL PRO TRP ASN SEQRES 22 A 357 ARG LEU PHE PRO ASN ALA ASP SER LYS ALA LEU ASP LEU SEQRES 23 A 357 LEU ASP LYS MET LEU THR PHE ASN PRO HIS LYS ARG ILE SEQRES 24 A 357 GLU VAL GLU GLN ALA LEU ALA HIS PRO TYR LEU GLU GLN SEQRES 25 A 357 TYR TYR ASP PRO SER ASP GLU PRO ILE ALA GLU ALA PRO SEQRES 26 A 357 PHE LYS PHE ASP MET GLU LEU ASP ASP LEU PRO LYS GLU SEQRES 27 A 357 LYS LEU LYS GLU LEU ILE PHE GLU GLU THR ALA ARG PHE SEQRES 28 A 357 GLN PRO GLY TYR ARG SER SEQRES 1 B 357 ALA ALA ALA ALA ALA ALA GLY PRO GLU MET VAL ARG GLY SEQRES 2 B 357 GLN VAL PHE ASP VAL GLY PRO ARG TYR THR ASN LEU SER SEQRES 3 B 357 TYR ILE GLY GLU GLY ALA TYR GLY MET VAL CYS SER ALA SEQRES 4 B 357 TYR ASP ASN LEU ASN LYS VAL ARG VAL ALA ILE LYS LYS SEQRES 5 B 357 ILE SER PRO PHE GLU HIS GLN THR TYR CYS GLN ARG THR SEQRES 6 B 357 LEU ARG GLU ILE LYS ILE LEU LEU ARG PHE ARG HIS GLU SEQRES 7 B 357 ASN ILE ILE GLY ILE ASN ASP ILE ILE ARG ALA PRO THR SEQRES 8 B 357 ILE GLU GLN MET LYS ASP VAL TYR ILE VAL GLN ASP LEU SEQRES 9 B 357 MET GLU THR ASP LEU TYR LYS LEU LEU LYS THR GLN HIS SEQRES 10 B 357 LEU SER ASN ASP HIS ILE CYS TYR PHE LEU TYR GLN ILE SEQRES 11 B 357 LEU ARG GLY LEU LYS TYR ILE HIS SER ALA ASN VAL LEU SEQRES 12 B 357 HIS ARG ASP LEU LYS PRO SER ASN LEU LEU LEU ASN THR SEQRES 13 B 357 THR CYS ASP LEU LYS ILE CYS ASP PHE GLY LEU ALA ARG SEQRES 14 B 357 VAL ALA ASP PRO ASP HIS ASP HIS THR GLY PHE LEU THR SEQRES 15 B 357 GLU TYR VAL ALA THR ARG TRP TYR ARG ALA PRO GLU ILE SEQRES 16 B 357 MET LEU ASN SER LYS GLY TYR THR LYS SER ILE ASP ILE SEQRES 17 B 357 TRP SER VAL GLY CYS ILE LEU ALA GLU MET LEU SER ASN SEQRES 18 B 357 ARG PRO ILE PHE PRO GLY LYS HIS TYR LEU ASP GLN LEU SEQRES 19 B 357 ASN HIS ILE LEU GLY ILE LEU GLY SER PRO SER GLN GLU SEQRES 20 B 357 ASP LEU ASN CYS ILE ILE ASN LEU LYS ALA ARG ASN TYR SEQRES 21 B 357 LEU LEU SER LEU PRO HIS LYS ASN LYS VAL PRO TRP ASN SEQRES 22 B 357 ARG LEU PHE PRO ASN ALA ASP SER LYS ALA LEU ASP LEU SEQRES 23 B 357 LEU ASP LYS MET LEU THR PHE ASN PRO HIS LYS ARG ILE SEQRES 24 B 357 GLU VAL GLU GLN ALA LEU ALA HIS PRO TYR LEU GLU GLN SEQRES 25 B 357 TYR TYR ASP PRO SER ASP GLU PRO ILE ALA GLU ALA PRO SEQRES 26 B 357 PHE LYS PHE ASP MET GLU LEU ASP ASP LEU PRO LYS GLU SEQRES 27 B 357 LYS LEU LYS GLU LEU ILE PHE GLU GLU THR ALA ARG PHE SEQRES 28 B 357 GLN PRO GLY TYR ARG SER HET HMY A 1 27 HET HMY B 1 27 HETNAM HMY (1AR,8S,13S,14S,15AR)-5,13,14-TRIHYDROXY-3-METHOXY-8- HETNAM 2 HMY METHYL-8,9,13,14,15,15A-HEXAHYDRO-6H- HETNAM 3 HMY OXIRENO[K][2]BENZOXACYCLOTETRADECINE-6,12(1AH)-DIONE HETSYN HMY HYPOTHEMYCIN FORMUL 3 HMY 2(C19 H22 O8) FORMUL 5 HOH *257(H2 O) HELIX 1 1 HIS A 59 PHE A 76 1 18 HELIX 2 2 LEU A 110 LYS A 115 1 6 HELIX 3 3 SER A 120 ALA A 141 1 22 HELIX 4 4 LYS A 149 SER A 151 5 3 HELIX 5 5 THR A 188 ARG A 192 5 5 HELIX 6 6 ALA A 193 ASN A 199 1 7 HELIX 7 7 LYS A 205 ASN A 222 1 18 HELIX 8 8 HIS A 230 GLY A 243 1 14 HELIX 9 9 SER A 246 ASN A 251 1 6 HELIX 10 10 ASN A 255 SER A 264 1 10 HELIX 11 11 PRO A 272 PHE A 277 1 6 HELIX 12 12 ASP A 281 LEU A 292 1 12 HELIX 13 13 GLU A 301 ALA A 307 1 7 HELIX 14 14 HIS A 308 GLU A 312 5 5 HELIX 15 15 ASP A 316 GLU A 320 5 5 HELIX 16 16 PRO A 337 THR A 349 1 13 HELIX 17 17 ALA A 350 GLN A 353 5 4 HELIX 18 18 HIS B 59 PHE B 76 1 18 HELIX 19 19 LEU B 110 LYS B 115 1 6 HELIX 20 20 SER B 120 ALA B 141 1 22 HELIX 21 21 LYS B 149 SER B 151 5 3 HELIX 22 22 ALA B 193 ASN B 199 1 7 HELIX 23 23 LYS B 205 ASN B 222 1 18 HELIX 24 24 HIS B 230 GLY B 243 1 14 HELIX 25 25 SER B 246 ILE B 253 1 8 HELIX 26 26 ASN B 255 LEU B 265 1 11 HELIX 27 27 PRO B 272 PHE B 277 1 6 HELIX 28 28 ASP B 281 LEU B 292 1 12 HELIX 29 29 GLU B 301 ALA B 307 1 7 HELIX 30 30 HIS B 308 GLU B 312 5 5 HELIX 31 31 PRO B 337 THR B 349 1 13 HELIX 32 32 ALA B 350 GLN B 353 5 4 SHEET 1 A 2 MET A 11 VAL A 12 0 SHEET 2 A 2 GLN A 15 VAL A 16 -1 O GLN A 15 N VAL A 12 SHEET 1 B 5 TYR A 23 GLU A 31 0 SHEET 2 B 5 GLY A 35 ASP A 42 -1 O TYR A 41 N THR A 24 SHEET 3 B 5 VAL A 47 ILE A 54 -1 O ILE A 51 N CYS A 38 SHEET 4 B 5 VAL A 99 ASP A 104 -1 O VAL A 99 N ILE A 54 SHEET 5 B 5 ASP A 86 ILE A 88 -1 N ILE A 88 O TYR A 100 SHEET 1 C 3 THR A 108 ASP A 109 0 SHEET 2 C 3 LEU A 153 LEU A 155 -1 O LEU A 155 N THR A 108 SHEET 3 C 3 LEU A 161 ILE A 163 -1 O LYS A 162 N LEU A 154 SHEET 1 D 2 VAL A 143 LEU A 144 0 SHEET 2 D 2 ARG A 170 VAL A 171 -1 O ARG A 170 N LEU A 144 SHEET 1 E 2 MET B 11 VAL B 12 0 SHEET 2 E 2 GLN B 15 VAL B 16 -1 O GLN B 15 N VAL B 12 SHEET 1 F 5 TYR B 23 GLY B 30 0 SHEET 2 F 5 MET B 36 ASP B 42 -1 O TYR B 41 N THR B 24 SHEET 3 F 5 ARG B 48 ILE B 54 -1 O LYS B 53 N MET B 36 SHEET 4 F 5 VAL B 99 ASP B 104 -1 O ILE B 101 N LYS B 52 SHEET 5 F 5 ASP B 86 ILE B 88 -1 N ILE B 88 O TYR B 100 SHEET 1 G 3 THR B 108 ASP B 109 0 SHEET 2 G 3 LEU B 153 LEU B 155 -1 O LEU B 155 N THR B 108 SHEET 3 G 3 LEU B 161 ILE B 163 -1 O LYS B 162 N LEU B 154 SHEET 1 H 2 VAL B 143 LEU B 144 0 SHEET 2 H 2 ARG B 170 VAL B 171 -1 O ARG B 170 N LEU B 144 LINK C11 HMY A 1 SG CYS A 164 1555 1555 1.62 LINK C11 HMY B 1 SG CYS B 164 1555 1555 1.62 SITE 1 AC1 12 ILE A 29 ALA A 50 GLN A 103 ASP A 104 SITE 2 AC1 12 LEU A 105 MET A 106 THR A 108 SER A 151 SITE 3 AC1 12 ASN A 152 LEU A 154 CYS A 164 ASP A 165 SITE 1 AC2 15 ILE B 29 ALA B 50 LYS B 52 GLN B 103 SITE 2 AC2 15 ASP B 104 LEU B 105 MET B 106 GLU B 107 SITE 3 AC2 15 LYS B 112 SER B 151 ASN B 152 LEU B 154 SITE 4 AC2 15 CYS B 164 ASP B 165 HOH B 501 CRYST1 45.815 117.298 65.871 90.00 89.82 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021827 0.000000 -0.000069 0.00000 SCALE2 0.000000 0.008525 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015181 0.00000